(Q73303550)

English

Treatment of repeated unexplained in vitro fertilization failure with intravenous immunoglobulin: a randomized, placebo-controlled Canadian trial

scientific article published on 01 December 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11119735%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Treatment of repeated unexplained in vitro fertilization failure with intravenous immunoglobulin: a randomized, placebo-controlled Canadian trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11119735%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

based on heuristic

inferred from title

author name string

M D Stephenson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11119735%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M R Fluker

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11119735%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

0 references

publication date

1 December 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11119735%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Fertility and Sterility

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11119735%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

74

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11119735%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11119735%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1108-1113

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11119735%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Reducing the Risk of Multiple Births by Transfer of Two Embryos after in Vitro Fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Prediction of implantation by the sonographic appearance of the endometrium during controlled ovarian stimulation for in vitro fertilization (IVF)

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Intravenous immunoglobulin (IVIG) in the prevention of implantation failures

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Intravenous immunoglobulin preceding in vitro fertilization-embryo transfer for patients with repeated failure of embryo transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Immunological treatment of implantation failure

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Intravenous immunoglobulin for in-vitro fertilization failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

The use of combined heparin/aspirin and immunoglobulin G therapy in the treatment of in vitro fertilization patients with antithyroid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

A rational basis for the use of combined heparin/aspirin and IVIG immunotherapy in the treatment of recurrent IVF failure associated with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Avoidance of triplet pregnancies by elective transfer of two good quality embryos

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

New treatments, preliminary results, and clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Hydrosalpinx and IVF outcome: a prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Suppression of immunoglobulin production of lymphocytes by intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

The use and mechanisms of action of intravenous immunoglobulin: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Parental human leukocyte antigens and implantation failure after in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Reproductive failure due to spontaneous abortion and recurrent miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Recurrent first trimester spontaneous abortion associated with antiphospholipid antibodies: a pilot study of treatment with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Pregnancy complicated by the antiphospholipid syndrome: outcomes with intravenous immunoglobulin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

Intravenous immunoglobulin therapy for recurrent spontaneous abortion: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

The effect of embryo quality on subsequent pregnancy rates after in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901622-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0015-0282(00)01622-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11119735%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11119735%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73303550&oldid=1909647630"